Apple has announced the appointment of a new leader for its team working on a noninvasive blood sugar monitor, signaling its continued commitment to pushing the boundaries of health technology. Tim Millet, Apple's vice president of platform architecture, has taken charge of the project after a period of transition following the death of the previous leader, scientist Bill Athas. The team, known as the Exploratory Design Group (XDG), had been overseen by Athas' former deputies on an ad-hoc basis. Now, Millet, a veteran executive with significant experience in iPhone and Mac chip development, will guide the team towards its ambitious goal.
Apple has been working on developing a noninvasive blood sugar monitor since around 2011, and recent reports indicate that the company has made significant progress in this area. The hope is that eventually, the monitor will be small enough to be incorporated into the Apple Watch. In the meantime, Apple has been adding various health-related sensors to its smartwatches, including those for blood oxygen and body temperature measurement. A blood pressure monitor is also reportedly in the works for release in the near future.
Millet's role in Apple's chip development is well-established, having been a key figure in the company's transition from Intel to its own M1 and M2 processors. He has played a prominent role in product presentations and media interviews, serving as the spokesperson for new Mac semiconductor designs. With his vast experience and expertise, Millet is expected to bring valuable insights and leadership to the Exploratory Design Group.
The team responsible for the glucose tracker is part of Apple's semiconductor organization, as the system relies on advanced chip-based technology. Using sensors and laser technology, the tracker measures glucose levels in the body, aided by artificial intelligence algorithms. Apple has reportedly shrunk the technology into an arm-worn device about the size of an iPhone and is now working on further miniaturization to make it suitable for a wrist-worn device.
While a consumer launch of the glucose monitor within an Apple Watch is still several years away, internal testing has reportedly been successful, providing confidence that the system works effectively. Apple's continuous investment in health-related technology highlights its commitment to expanding its presence in the healthcare sector and providing users with innovative and convenient health monitoring solutions.